# OnCo record shine-on-biomedical (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/shine-on-biomedical/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "shine-on-biomedical" ;
  schema:name "Shine-On Biomedical"@en ;
  schema:alternateName "Shine-On Biomedical Co., Ltd."@en ;
  schema:description "Shine-On Biomedical is a Taiwanese company developing an antibody made from small nanobody parts that grabs two markers on cancer cells and links them to the immune system's T cells. It is in an early trial in advanced solid tumours; the company also develops targeted exosomes to deliver cancer drugs."@en ;
  schema:url <https://onco.cc/companies/shine-on-biomedical/>, <https://www.shineon-bio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.shineon-bio.com/>, <https://www.shineon-bio.com/products2_detail/5> ;
  schema:addressCountry "TW" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/trispecific-antibodies/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/pdl1/>, <https://onco.cc/targets/cd3/>, <https://onco.cc/targets/epha10/> ;
  onco:trials <https://onco.cc/trials/nct07055594/> .